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OBJECTIVES This study was performed to determine the association between clinical characteristics,
particularly body mass and race, and the likelihood of hypertension as the primary etiology for
heart failure (HTNCM).
BACKGROUND Although held to be important in the development of heart failure, the clinical characteristics
predictive of HTNCM have not been well delineated.
METHODS The study analysis was conducted using 680 patients from the University of North Carolina
Heart Failure Database. This data set is racially diverse (44% African-American) and contains
data concerning baseline clinical characteristics and cardiac function in patients with and
without HTNCM. Logistic regression techniques determined independent predictors of
HTNCM among the entire study population as well as the subgroup of study patients with
hypertension.
RESULTS Hypertension was present in 51% of the study patients but was the primary etiology of heart
failure in only 25%. Body mass, race, gender and baseline systolic blood pressure were
identified as significant independent predictors of the likelihood of HTNCM (all p , 0.001).
These characteristics were predictors in the total study population and also in the subgroup
of study patients with hypertension.
CONCLUSIONS Hypertension remains a common etiologic factor for the development of heart failure but was
the primary cause of heart failure in a minority of study patients. However, the presence of
increased body mass, female gender, African-American ethnic origin or elevated baseline
systolic blood pressure significantly increased the likelihood of HTNCM. (J Am Coll
Cardiol 1999;34:1602–8) © 1999 by the American College of Cardiology
Natural history studies continue to demonstrate that sys-
temic hypertension is a significant risk factor for the
development of heart failure (1). Part of the explanation for
the association between heart failure and hypertension arises
from the increased risk of coronary artery disease (CAD)
and myocardial infarction among hypertensives. However,
clinical observation continues to suggest that hypertension
may be the sole apparent cause for heart failure.
Despite this clinical impression, the characteristics asso-
ciated with hypertension as the principal cause of heart
failure, in the absence of other etiologic factors like CAD,
have not been well delineated. Prior studies suggest that
obesity might be a significant predictor for the development
of hypertension-associated heart failure (2). Even in the
absence of hypertension, increased body mass has been
correlated with the development of left ventricular hyper-
trophy (3–5), and marked obesity is associated with cardio-
myopathy (6,7). Studies of cardiac structure have demon-
strated the adverse consequences when obesity and
hypertension coexist. Cardiac remodeling, as evidenced by left
ventricular dilatation and hypertrophy, is greater in patients
with obesity and hypertension compared with patients with
hypertension alone and could predispose patients to develop
left ventricular dysfunction and clinical heart failure (8–12).
Early work by Blake et al. (8) demonstrated that left ventricular
dysfunction during exercise in hypertensive patients was asso-
ciated with eccentric ventricular hypertrophy and increased
body mass. The potential association between female gender,
African-American race and hypertension as the primary etiol-
ogy of heart failure (HTNCM) deserves further investigation
as well. Hypertension and obesity are particularly frequent in
black females and seem to be important contributors to
cardiovascular disease in this demographic group (13).
The potential association between these factors and
HTNCM was investigated using the University of North
Carolina (UNC) Heart Failure Database. This data set has
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a substantial minority of African-American and female
patients, and all patients enrolled have well-delineated
baseline clinical characteristics (14). The study patients were
categorized according to the presence or absence of hyper-
tension and, when hypertension was present, whether it was
a coetiology or the only apparent cause of heart failure.
Logistic regression methods were used to determine which
baseline clinical characteristics were predictors of HTNCM.
METHODS
UNC Heart Failure Database. The present study utilizes
data from the UNC Heart Failure Database, the entry
criteria and design of which have been described in detail
elsewhere and remain unchanged in this latest patient group
(13). A brief review of the database focusing on a few
specific aspects particularly relevant for this work follows
below.
Definition of hypertension. Patients were given a diagno-
sis of hypertension by study criteria (HTNDX) if they had
a history of this disorder and evidence of at least one of the
following: 1) current or previous administration of medica-
tion specifically as antihypertensive pharmacologic treat-
ment or 2) blood pressure readings of $140 mm Hg systolic
or $90 mm Hg diastolic on at least three separate occasions
before or within three months after their study entry date
(15).
Etiologic classification. The presence or absence of CAD
was determined in the study patients as previously reported
(13). The presence of CAD was established in 239 patients
based on: 1) angiographic (191 patients) or autopsy (10
patients) results demonstrating 70% or greater stenosis of at
least one major epicardial coronary artery; 2) prior myocar-
dial infarction documented by standard electrocardiographic
or enzymatic criteria (34 patients); or 3) the presence of
typical angina and a stress radionuclide examination consis-
tent with ischemia (4 patients). Coronary artery disease was
absent in 264 patients based on angiographic (248 patients)
or autopsy (16 patients) results. A total of 177 study patients
were determined not to have CAD based on the following
clinical criteria: no evidence of previous myocardial infarc-
tion by history or electrocardiographic findings and no
history of angina pectoris.
Available clinical, laboratory and autopsy data were uti-
lized to assign a primary etiology for heart failure in each
patient as previously described (13). Ischemic heart disease
was the primary cause in 211 of the 239 patients with
evidence of CAD. Specific criteria were utilized to establish
alcohol, valvular heart disease, peripartum cardiomyopathy
or other rarer but well-recognized primary causes of heart
failure in 188 study patients (13,16). HTNCM was assigned
in 168 patients with HTNDX and no other specific cause of
cardiomyopathy. Idiopathic cardiomyopathy was the pri-
mary etiology in the remaining 113 study patients. Hyper-
tension was assigned as a coetiology in 178 patients with
HTNDX who also met study criteria for another potential
etiology of heart failure.
Body habitus. Self-reported height and body weight given
at the time of the qualifying radionuclide ventriculogram
were used in the study analysis. Previous studies attest to the
accuracy of patient estimates of height and weight (17–19).
Our own validation study in 100 consecutive study patients
demonstrated that height and body weight measured in the
clinic were highly correlated with self-reported values (for
height, r 5 0.99, p , 0.0001; for weight, r 5 0.97, p ,
0.0001). Patients were categorized as overweight if they
exceeded the following body mass criteria proposed by the
National Institutes of Health Consensus Development Pan-
el: for men .27.8 kg/m2, and for women .27.3 kg/m2 (20).
Patients were obese if their body mass exceeded 30 kg/m2.
Morbid obesity was defined as a body weight greater than
136 kg (7).
Statistical analysis. Data are presented as the mean 6
standard error of the mean. Differences in categorical and
continuous variables between various study groups were
assessed by the chi-square test or analysis of variance
methods as appropriate.
The principal study analysis was made to determine
independent predictors of HTNCM by stepwise, multi-
variate logistic regression in the subset of patients with
HTNDX (21). Two indices of body habitus, body weight as
overweight based on the criteria above or body mass divided
into quintiles, along with the following clinical characteris-
tics, were considered as predictors in the modeling analysis:
race coded as black versus other, gender, age, presence or
absence of electrocardiographic evidence of left ventricular
hypertrophy (EKGLVH), history of diabetes, years of
hypertension and the resting systolic blood pressure ob-
tained at study entry (22). Each significant predictor was
then confirmed in a backward selection process with all
potential characteristics forced into the model. Additional
modeling was undertaken in two subsets of HTNDX
patients created: 1) after exclusion of 13 patients who met
study criteria for morbid obesity or 2) after exclusion of 109
patients in whom the absence of CAD was determined by
clinical criteria alone, as well as three additional patients
with a primary etiology of hypertension but angiographic
evidence of significant single-vessel CAD (.70% stenosis
of either the right or circumflex coronary artery). Multicat-
Abbreviations and Acronyms
CAD 5 coronary artery disease
EKGLVH 5 electrocardiographic evidence of left
ventricular hypertrophy
HTNCM 5 hypertension as the primary etiology of
heart failure
HTNDX 5 diagnosis of hypertension by study criteria
NYHA 5 New York Heart Association
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egory logistic modeling was also performed to determine
predictors of hypertensive status (no diagnosis of hyperten-
sion, hypertension as a coetiology and HTNCM) in the
total study population (680 patients).
RESULTS
Study population. The majority of the 680 total study
patients were New York Heart Association (NYHA) func-
tional class II (29%) or III (50%); only 14 patients (2.1%)
were NYHA class I at entry. The mean left ventricular
ejection fraction was 26% 6 0.5%. The mean body weight
for the study population was 81 6 0.8 kg, and the mean
body mass was 27 6 0.3 kg/m2. The percentage of study
patients in each category of body habitus is shown in Figure
1. The mean age of the total study population was 51 6 0.5
years, with women comprising 31% of the total patients,
while 44% were African-American.
The 346 patients in the total study group with HTNDX
had a mean left ventricular ejection fraction of 27 6 0.7,
with 41 patients (12%) in this subset having a value greater
than 45%. The race-gender distribution in patients with
HTNDX was: 70 (20.2%) black females, 42 (12.1%) non-
black females, 129 (37.3%) black males and 105 (30.3%)
nonblack males.
Hypertensive etiology. A history of elevated blood pres-
sure was present in 55% of the study population, while 51%
met the study criteria for hypertension. The frequency of the
diagnosis of hypertension varied significantly by racial
group, with blacks more likely to have this characteristic
than nonblacks (67% vs. 39%, p , 0.0001). Despite its
underlying frequency, hypertension was assigned as the
primary etiology of heart failure in only 25% of the study
patients. Comparisons of clinical characteristics based on
hypertensive status suggested potential predictors of
HTNCM (Table 1). In addition to racial makeup, body
mass, gender, systolic blood pressure, left ventricular ejec-
tion fraction, history of diabetes and EKGLVH demon-
strated overall differences between these groups. Compari-
son of these characteristics between patients with HTNCM
versus patients with hypertension as a coetiology demon-
strated significant differences (p , 0.05) for all except those
with history of diabetes (p 5 0.611).
Figure 1. Distribution of body habitus in the total study popula-
tion. By the criteria specified in the study methods, a substantial
minority of the study patients were overweight and obese, but
morbid obesity was uncommon. NL 5 nonoverweight, OB 5
obesity, OVERWT 5 overweight.
Table 1. Differences in Clinical Characteristics Based on the Relationship of Hypertension to
Etiology of Heart Failure
Characteristic HTNCM
Non-HTNCM
p ValueHTN Coetiology No HTN
n 168 178 334
Age (yrs) 53 6 1.0 54 6 1.0 49 6 1.0 , 0.001
Body habitus
Height (cm) 172 6 1.0 173 6 1.0 173 6 1.0 0.768
Weight (kg) 91 6 2.0 80 6 1.5 77 6 1.0 , 0.001
Body mass (kg/m2) 30 6 0.6 27 6 0.6 26 6 0.4 , 0.001
SBP (mm Hg) 134 6 1.8 123 6 1.5 112 6 0.9 , 0.001
LVEF (%) 30 6 1.1 24 6 0.9 24 6 0.7 , 0.001
Caucasian (%) 26 54 68 0.001
EKG LVH (%) 56 45 33 0.001
History of:
Hypertension (%) 100 100 8 0.001
Diabetes (%) 30 27 17 0.003
CABG (%) 0 27 13 0.001
Results are shown as mean 6 SEM. p values reflect overall differences across the three types of hypertensive status.
CABG 5 coronary artery bypass surgery; EKG LVH 5 left ventricular hypertrophy by EKG criteria; HTN Coetiology 5
patients with study diagnosis of hypertension but another potential etiology heart failure; LVEF 5 left ventricular ejection
fraction; No HTN 5 patients not meeting study criteria for hypertension; SBP 5 systolic blood pressure.
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Associations in all patients. In the total study population,
as the body mass increased, HTNCM was more likely (Fig.
2). A similar relationship was observed when body habitus
was categorized according to the study criteria for over-
weight or obesity. Hypertension was the primary etiology of
heart failure in 40% of overweight patients versus 17% of
patients who were not overweight (p , 0.001), while 45% of
the obese patients had HTNCM versus 18% of the nono-
bese patients (p , 0.001). In the total study population,
blacks were significantly more likely than nonblacks (40%
vs. 7.1%, p , 0.001) and females significantly more likely
than males (34% vs. 21%, p , 0.001) to have HTNCM.
The combined associations of racial group and gender with
the likelihood of hypertension and heart failure due to
hypertension are shown for the total study population in
Figure 3.
Hypertensive patients. Similar relationships were seen
when body mass, race and gender were considered as
predictors of the likelihood of HTNCM in the subset of
study patients with HTNDX (Fig. 4). A threshold relation-
ship between body mass and the likelihood of HTNCM
was most evident for nonblack males. By contrast, black
patients of either gender and nonblack females tended to
have increasing likelihood of HTNCM with each increment
in body mass quintile. The likelihood of HTNCM appeared
greatest in obese black females and lowest in lean nonblack
males (p 5 0.02 for the pair-wise comparison of the slope of
the relationship between body mass quintile and likelihood
of HTNCM in these two groups) (Fig. 4).
Multivariate modeling in the subset with HTNDX dem-
onstrated that overweight, race, gender and baseline systolic
blood pressure were significant independent predictors of
the likelihood of HTNCM after taking into account a
variety of clinical factors including age, the presence or
absence of EKGLVH and years of hypertension (Table 2).
Body mass quintile was a significant predictor when substi-
tuted for overweight in the final model (odds ratio [OR]
1.43; 95% confidence interval [CI] 1.20 to 1.71; p ,
0.0001). History of diabetes was not a significant predictor
for the likelihood of HTNCM (OR for a positive vs.
Figure 2. The relationship between body mass quintile and the
likelihood of HTNCM in the total patient population. Increasing
body mass is associated with progressive risk of HTNCM.
Figure 3. The percentage of patients with HTNDX and HT-
NCM based on race and gender. The racial category is black versus
nonblack. HTNDX is more common in black patients, while
HTNCM is most common in black females and least common in
other males. BF 5 black female, BM 5 black male, OF 5 other
female, OM 5 other male.
Figure 4. The percentage of patients with HTNCM is shown by
race and gender for various body mass quintiles among patients
with HTNDX. The complex relationship of race, gender and body
mass to the likelihood of HTNCM is reflected. Solid squares 5
black females; solid circles 5 black males; open squares 5 other
females; open triangles 5 other males.
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negative history 0.84; CI 0.49 to 1.46; p 5 0.542). The
characteristics in Table 2 remained significant predictors
when patients with morbid obesity were excluded. Addi-
tional modeling was performed in 234 of the 346 study
patients with HTNDX (68%) who had their CAD status
well documented. Multivariate analysis in this subset
yielded the same predictors for HTNCM as found for all
346 patients with hypertension.
Associations by hypertensive status. Multicategory logis-
tic regression modeling confirmed overweight, race and
baseline systolic blood pressure as significant independent
predictors of HTNCM not only for the comparison of
patients when hypertension was primary versus a coetiology
but also for primary versus nonhypertensive patients (Table
3). There was a strong trend for gender to be a predictor in
both comparisons as well. Age and EKGLVH emerged as
marginally significant predictors in the primary versus co-
etiology comparison done as part of the multicategory
regression. Only trends toward significance were present for
these variables when hypertensive study patients alone were
modeled.
DISCUSSION
Our study makes an important contribution toward under-
standing the current role of hypertension in heart failure.
The seminal investigation of the Framingham cohort estab-
lished the important role played by hypertension in the
promotion of symptomatic left ventricular dysfunction
(1,23). By contrast, recent studies based on clinical trial data
sets have emphasized the importance of ischemic heart
disease as an etiologic factor for heart failure. Through the
UNC Heart Failure Database, our study provides a unique
opportunity to investigate the role of hypertension in heart
failure in a diverse, contemporary patient population well
characterized with respect to potential etiologic factors. In
agreement with the Framingham results, hypertension was
found to be a common, important causal factor for heart
failure in our patients, a total of 51% of whom met the study
criteria for the diagnosis of hypertension. By contrast,
hypertension appeared to be the sole etiologic factor for
heart failure in a minority of study patients (25%). By
carefully defining study patients with HTNCM, our anal-
ysis delineated the specific clinical characteristics that sig-
nificantly influenced the risk of hypertension as the sole
apparent cause of heart failure. High body mass, female
gender, African-American ethnic origin and elevated base-
line systolic blood pressure significantly increased the like-
lihood of having HTNCM. Multivariate logistic regression
confirmed the importance of these factors as independent
predictors of HTNCM both among patients with the
diagnosis of hypertension and in the total study population.
Specific predictors. Body weight has long been appreci-
ated as a modulator of cardiac anatomy and function and
more recently as a possible contributor to the development
of heart failure (24). We found that excess body mass
was strongly associated with greater likelihood of having
HTNCM. The relationship between increasing body mass
and greater likelihood of HTNCM reflected differences in
body weight, not height. Although morbid obesity has been
previously associated with the development of cardiomyop-
athy (25,26), this degree of adiposity was rare in our study
population. In fact, the relationship to body mass was
detected even though the median body weight of patients
with HTNCM was 190 lbs and the median body mass was
29.3 m/kg2, with 42% of the patients failing to meet
standard criteria for overweight. Our data suggest that body
Table 2. Predictors of HTNCM in Hypertensive Study Patients
Characteristic
Odds
Ratio 95% CI p Value
Overweight 2.52 1.52–4.15 0.0003
African-American race 2.83 1.71–4.69 , 0.0001
Female gender 2.68 1.56–4.61 0.0004
Baseline systolic blood
pressure (per 5 mm Hg)
1.13 1.07–1.20 , 0.0001
Overweight is defined as patients exceeding the following body mass criteria: for
men . 27.8 kg/m2 and for women . 27.3 kg/m2. p values are based on logistic
regression analysis. CI 5 confidence interval.









Odds Ratio p Value Odds Ratio p Value Odds Ratio p Value
African-American race 6.99 , 0.001 2.35 , 0.001 2.98 , 0.001
Age (per 10 yrs) 1.81 , 0.001 1.49 , 0.001 1.25 0.046
Female gender 0.61 0.057 1.36 0.193 0.45 0.002
Overweight 4.38 , 0.001 1.76 0.012 2.49 , 0.001
Systolic blood pressure
(per 5 mm Hg)
1.33 , 0.001 1.18 , 0.001 1.12 , 0.001
EKG LVH 2.47 , 0.001 1.46 0.080 1.69 0.035
Abbreviations are the same as in Table 1.
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mass may predispose to HTNCM with only modest in-
creases in body weight above established norms.
The work of Messerli et al. (9) has demonstrated the
additional hemodynamic burden that obesity places on the
hypertensive heart. Their studies of cardiac performance
and structure in obese hypertensive patients have demon-
strated increased stroke volume and left ventricular dilation
compared with normal subjects. Results from an unselected
population of hypertensive patients demonstrated that the
obese patients maintained a similar cardiac index compared
with normal-weight subjects but did so through ventricular
dilation and the use of preload reserve (10). A number of
studies in hypertensive populations have found that obesity
is the strongest clinical predictor of left ventricular hyper-
trophy and increased left ventricular mass (11), factors
known to be associated with the risk of developing heart
failure (12). The review by Reaven et al. (27) provides some
additional insight into the mechanisms that may account for
the association between increased body mass and risk of
developing heart failure among patients who are hyperten-
sive. Increased body mass appears to promote greater activation
of the sympathetic nervous system. Natural history studies and
the therapeutic benefit of beta-blockade in heart failure attest
to the pathophysiologic importance of the sympathetic nervous
system and point to a role for this factor in hypertension-
associated heart failure (28,29).
Other predictors. Our findings demonstrated that
African-American ethnicity significantly increased the like-
lihood of hypertension being the predominant cause of heart
failure. Hypertension is known to be more common among
blacks and has been associated with greater mortality and
morbidity due to cardiovascular disease and renal failure in
this ethnic group compared with Caucasians (30,31). Data
reported by Bourassa et al. (32) from the SOLVD registry
supports our finding that hypertension was more commonly
the primary etiology of heart failure in African-Americans.
Whether this racial difference reflects underlying differences
in the biology of hypertension in blacks or differences in
access to care or in treatment compliance remains to be
determined. Hinderliter et al. (33) have found differences in
ventricular geometry between healthy blacks and whites,
suggesting fundamental racial disparities in cardiac mor-
phology during normal aging. Gottdiener et al. (11) found
that the incidence of left ventricular hypertrophy by echo-
cardiographic criteria was similar in blacks and Caucasians
enrolled in a clinical trial of antihypertensive agents, but that
relative wall thickness was increased in black males com-
pared with white males. These findings suggest the possi-
bility that clinically important differences in left ventricular
adaptation to hypertension may occur in black and white
patients. We found that females were significantly more
likely than males to have hypertension as their primary
etiologic factor for heart failure. This disparity likely reflects
the relative lack of ischemic heart disease in women,
particularly in the age group we studied. Gender might not
be a predictor in an elderly cohort, where the likelihood of
ischemic cardiomyopathy in females would increase. In
addition, the findings of de Simone et al. (3) concerning
differences in hypertrophy between males and females may
help explain our results. They found that coexisting obesity
and hypertension were more likely to increase left ventric-
ular mass-to-height ratios in females compared with males.
We did not find that diabetes was a predictor of hyperten-
sion as the primary etiology of heart failure. This may be
attributed to the etiologic classification we used. Patients
with hypertension as a coetiology (typically along with
CAD) were separated from those patients in which hyper-
tension was the only apparent etiology of heart failure.
Study limitations. Our study utilized a cross-sectional
design to test the association of specific clinical character-
istics with the outcome of interest: heart failure due to
hypertension. Our design has the advantage of identifying
many patients with this form of heart failure, which is
infrequent in clinical studies of hypertensive patients. How-
ever, our study structure does not allow us to determine
cause-and-effect relationships between the predictors we
have identified and the likelihood of HTNCM. Our study
population was limited to a single center and was relatively
youthful. Additional studies in a broader patient population
will help confirm the generalizability of our findings. Our
population had predominantly systolic ventricular dysfunc-
tion. Studying a larger sample size of patients with preserved
systolic function might yield a model different from the one
we found. Data on coronary anatomy were not available in
all study patients, and this may have prevented identification
of ischemic heart disease as the primary etiology of heart
failure in some subjects. This could have biased the deter-
mination of the predictors of hypertension as the primary
etiology of heart failure. However, the same predictors were
found when modeling was conducted in the subset of study
patients who had their CAD status well documented.
Conclusions. Hypertension remains a common, important
etiologic factor but was the primary cause of heart failure in
a minority of study patients. Increased body mass, African-
American ethnicity and female gender all appear to be
factors associated with the likelihood of developing
HTNCM. Although cause and effect have not been estab-
lished, our study supports another potential benefit from
weight reduction in patients with hypertension, especially
black females.
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